Allchem Lifescience Limited IPO Details

MAINBOARD

Allchem Lifescience IPO DRHP (Draft Red Herring Prospectus) has been SEBI Approval Received.

The Lead Managers for Allchem Lifescience IPO are crucial for the offering's success. They are responsible for a wide range of tasks, including preparing the company for the public market, managing the regulatory filings, and marketing the IPO to potential investors. The lead manager for this offering is Emkay Global Financial Services Ltd. To assess their past performance and success in previous IPOs, you can view the Lead Manager Performance Summary report.

For detailed information, Refer to the Allchem Lifescience Limited DRHP.

Allchem Lifescience IPO Details

Open Date

Close Date

Listing Date

Issue Price

₹0 - ₹0

Face Value

₹10 per share

Lot Size

GMP

₹0

Issue Type

IPO

Listing On

NSE, BSE

Type

Book Built Issue

Share holding pre issue

76540230

Share holding post issue

Total Issue Size

Fresh Issue

Offer for Sale

DRHP Status

SEBI Approval Received

Allchem Lifescience IPO Lot Size

Application	Lots	Shares	Amount
To be announced

Allchem Lifescience IPO Reservation

Promoter Holding

Pre Issue:100%

Post Issue:-

Promoter Names:

Bipin Patel, Manisha Bipin Patel, Kantilal Ramanlal Patel, Aditi Patel

Documents

› Allchem Lifescience IPO DRHP

Allchem Lifescience IPO Valuations

ROE:34.33%

ROCE:22.87%

DEBT/EQUITY:1.31

RONW:34.33%

PAT MARGIN:17.03%

Allchem Lifescience Financial Information

Period Ended	30 Sep 2024	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	246.3	224.65	186.68	124.02
Total Income	78.53	138.07	106.03	109.42
Profit After Tax	10.89	23.41	17.99	14.14
Net Worth	90.74	79.89	56.49	38.58
Reserves and Surplus	86.49	75.64	52.24	35.08
Total Borrowing	106.9	104.97	97.17	49.53
Amount in ₹ Crore

About Allchem Lifescience IPO

Incorporated in 2017, Allchem Lifescience Limited is manufacturer of active pharmaceutical ingredient (API) intermediates and specialty chemicals. The company focuses on producing key starting materials (KSMs), generic API intermediates, and speciality chemicals to cater to both domestic and international pharmaceutical and chemical industries.

Business Verticals

Allchem Lifescience Limited operates through two primary business segments:

Manufacturing API Intermediates
- API intermediates are essential chemical compoundsused in the production of active pharmaceutical ingredients (APIs) and finished drugs.
- These intermediates serve as crucial building blocks in synthesis processes, undergoing transformations that result in the final API or drug formulation.
Specialty or Fine Chemicals
- Specialty chemicals, also known as performance chemicals, are custom-designed substances for specific applications.

Product Portfolio & Capabilities

Allchem Lifescience Limited has developed the capability to manufacture 263 products, demonstrating expertise in various organic chemical compounds and advanced chemistries.

Clientele

The company serves a diverse range of domestic and international customers, including:

Indian Clients: Alembic Pharmaceuticals Limited, Indoco Remedies Limited, Megafine Pharma (P) Limited, Micro Labs Limited, MSN Laboratories Private Limited, Neogen Chemicals Limited, Neuland Laboratories Limited, Unichem Laboratories Limited, Vasudha Pharma Chem Limited, and more.
International Clients: Bond Chemical Limited, Chemosyntha BV, Cohance Life Sciences Limited, Egene Co Limited, Hattori Corporation, Huaian Jiamu Biotechnology Co. Limited, Moehs Iberica, S.L., Nagase India Private Limited, Olon Active Pharmaceutical Ingredients India Private Limited, and Vivatis Pharma GmbH.

Manufacturing & Infrastructure

Manufacturing Facility: Located in Village Manjusar, Vadodara, Gujarat
Total Equipment Capacity (as of December 31, 2024): 1,133.50 KL
Permanent Employees (as of December 31, 2024): 430

Strength Of Allchem Lifescience IPO

To be announced

Risk Of Allchem Lifescience IPO

To be announced

Objectives Allchem Lifescience IPO

1. Repayment or pre-payment, in full or in part, of certain of the outstanding borrowings availed by the Company.

2. General corporate purposes

Company Contact Details

Allchem Lifescience Ltd.
Block No. 1088/B/P, 1088-A, Lamdapura Road,
Village Manjusar,
Tal-Savli
Vadodara, Gujarat, 391775
Phone: +91-9574722211
Email: investor@allchemlifescience.com
Website: http://www.allchemlifescience.com/

Registrar Contact Details

Name: MUFG Intime India Private Limited

Phone: +91-22-4918 6270

Email: allchemlifescience.ipo@in.mpms.mufg.com

Website: https://in.mpms.mufg.com/Initial_Offer/public-issues.html

Lead Mangers

Emkay Global Financial Services Ltd
(Past IPO Performance)

Lead Manager Reports

IPO Lead Manager Performance Summary